drugset / Trial / NCT06291207
A Study to Evaluate the Efficacy and Safety of AD-224
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of AD-224
Timeline
- Start
- 2024-04-15
- Primary completion
- 2025-07
- Completion
- 2025-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AD-224A | Unknown | — | Oral |
| Subject | AD-224B | Unknown | — | Oral |
| Comparator | AD-224C | Unknown | — | Oral |